EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is the Cally index truly a prognostic marker that predicts mortality in older patients with acute coronary syndrome?

Ebru Serin, Mert Sarılar, Sinan Şahin, Arzu Er Kara, Hasan Değirmenci, Erol Kalender, Ahmet Gürdal, Kudret Keskin

Frontiers in Cardiovascular Medicine · 23.07.2026 · 13

DOI: 10.3389/fcvm.2026.1837291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 23.07.2026. Verfasst von Ebru Serin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The C-reactive protein (CRP) -albumin- lymphocyte (CALLY) index has recently emerged as a promising prognostic marker, which reflecting inflammatory, nutrional and immunological statuses. However, no study has reported the prognostic value of the CALLY index in older patients with acute coronary syndrome (ACS). The aim of the study is to determine whether the CALLY index can serve as a reliable predictor of all- cause mortality in older patients with ACS.

Methods

This study was conducted retrospectively in patients aged ≥ 75 years old with ACS. The study comprised 440 patients diagnosed with ACS at our hospital May 2015 to August 2024. The median follow-up time was 23 months. The CALLY index was computed using the formula: (serum albumin (g/dL)×lymphocyte (10 9 /L)/CRP (mg/L)×10). The primary outcome was all-cause mortality from the day of admission.

Results

A total of 475 ACS patients over 75 years old were ultimately enrolled in this study. 35 patients were excluded due to missing follow-up data and active infection. The patients were divided into two groups according to the CALLY index: low CALLY (≤ 0.083, n:219), high CALLY (> 0.083, n:221). The low CALLY index appears to be a valuable tool for predicting mortality in older patients with ACS. Kaplan–Meier analysis demonstrated that a low CALLY index was significantly associated with low survival rate. Our study revealed that the CALLY index provides statistically significant independent predictor in older patients' prognosis in all-cause mortality. All- cause mortality was 48.2% (n:212) in both groups. In the low CALLY index group, a higher rate of all- cause mortality was observed [group 1, n:130 (59.4%)].

Conclusions

Based on the findings of our study, the CALLY index appears to be a practical and easily applicable tool for assessing mortality risk in elderly patients with acute coronary syndrome.

Schlagwörter

Stichwörter der Autor:innen

CALLY indexacute coronary syndromebiomarkermortalityolder patients

Autor:innen und Institutionen

  • Department of Cardiology, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.

Zitieren

APA

Serin, E., Sarılar, M., Şahin, S., Er Kara, A., Değirmenci, H., Kalender, E., Gürdal, A., & Keskin, K. (2026). Is the Cally index truly a prognostic marker that predicts mortality in older patients with acute coronary syndrome?. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1837291

Vancouver

Serin E, Sarılar M, Şahin S, Er Kara A, Değirmenci H, Kalender E, et al. Is the Cally index truly a prognostic marker that predicts mortality in older patients with acute coronary syndrome?. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1837291

BibTeX
@article{Serin2026,
  author = {Serin, Ebru and Sarılar, Mert and Şahin, Sinan and Er Kara, Arzu and Değirmenci, Hasan and Kalender, Erol and Gürdal, Ahmet and Keskin, Kudret},
  title = {Is the Cally index truly a prognostic marker that predicts mortality in older patients with acute coronary syndrome?},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1837291}
}
Kostenlos starten →